These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 33574121)
1. Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity. Anderson J; Do LAH; Wurzel D; Quan Toh Z; Mulholland K; Pellicci DG; Licciardi PV Thorax; 2021 Sep; 76(9):942-950. PubMed ID: 33574121 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215 [TBL] [Abstract][Full Text] [Related]
3. Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis. Vu LD; Siefker D; Jones TL; You D; Taylor R; DeVincenzo J; Cormier SA Am J Respir Crit Care Med; 2019 Dec; 200(11):1414-1423. PubMed ID: 31237777 [No Abstract] [Full Text] [Related]
4. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants. High M; Cho HY; Marzec J; Wiltshire T; Verhein KC; Caballero MT; Acosta PL; Ciencewicki J; McCaw ZR; Kobzik L; Miller-DeGraff L; Gladwell W; Peden DB; Serra ME; Shi M; Weinberg C; Suzuki O; Wang X; Bell DA; Polack FP; Kleeberger SR EBioMedicine; 2016 Sep; 11():73-84. PubMed ID: 27554839 [TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. Groothuis JR; Simoes EA; Hemming VG Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741 [TBL] [Abstract][Full Text] [Related]
7. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome. Fonseca W; Lukacs NW; Ptaschinski C Front Immunol; 2018; 9():226. PubMed ID: 29515570 [TBL] [Abstract][Full Text] [Related]
8. van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038 [TBL] [Abstract][Full Text] [Related]
9. The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil. Arruda E; Jones MH; Escremim de Paula F; Chong D; Bugarin G; Notario G; Matsuno AK; Pitrez PM; Vo P; Suzuki C; Rosario Filho N; Stein RT Pediatr Infect Dis J; 2014 Oct; 33(10):997-1003. PubMed ID: 25361184 [TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants. McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190 [TBL] [Abstract][Full Text] [Related]
11. Are late preterm infants as susceptible to RSV infection as full term infants? Resch B; Paes B Early Hum Dev; 2011 Mar; 87 Suppl 1():S47-9. PubMed ID: 21276672 [TBL] [Abstract][Full Text] [Related]
12. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease. San-Juan-Vergara H; Peeples ME Immunol Allergy Clin North Am; 2019 Aug; 39(3):321-334. PubMed ID: 31284923 [TBL] [Abstract][Full Text] [Related]
13. Differential anti-viral response to respiratory syncytial virus A in preterm and term infants. Anderson J; Imran S; Ng YY; Wang T; Ashley S; Minh Thang C; Quang Thanh L; Thi Trang Dai V; Van Thanh P; Thi Hong Nhu B; Ngoc Xuan Trang D; Thi Phuong Trinh P; Thanh Binh L; Thuong Vu N; Trong Toan N; Novakovic B; Tang MLK; Wurzel D; Mulholland K; Pellicci DG; Do LAH; Licciardi PV EBioMedicine; 2024 Apr; 102():105044. PubMed ID: 38447274 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost. Atkins JT; Karimi P; Morris BH; McDavid G; Shim S Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001 [TBL] [Abstract][Full Text] [Related]
15. Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE). Larkin EK; Gebretsadik T; Moore ML; Anderson LJ; Dupont WD; Chappell JD; Minton PA; Peebles RS; Moore PE; Valet RS; Arnold DH; Rosas-Salazar C; Das SR; Polack FP; Hartert TV; BMC Pulm Med; 2015 Apr; 15():45. PubMed ID: 26021723 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity? Drajac C; Laubreton D; Riffault S; Descamps D J Immunol Res; 2017; 2017():8734504. PubMed ID: 29250560 [TBL] [Abstract][Full Text] [Related]
17. Should respiratory care in preterm infants include prophylaxis against respiratory syncytial virus infection? The case in favour. Resch B; Resch E; Müller W Paediatr Respir Rev; 2013 Jun; 14(2):130-6. PubMed ID: 23375547 [TBL] [Abstract][Full Text] [Related]